Hanekamp D, Ngai LL, Janssen JJ, van de Loosdrecht AA, et al. Early assessment of clofarabine effectiveness applying measurable residual
disease, including AML stem cells. Blood 2020 Nov 10. pii: 474126. doi: 10.1182/blood.2020007150.
PMID: 33171485